Jumpcan

Jumpcan is a national high-tech enterprise group integrating three major industries: Chinese and Western medicine, traditional Chinese medicine (TCM) daily chemicals, and TCM health products. It is a key pharmaceutical industry enterprise under the National Torch Program, one of the top 100 pharmaceutical manufacturing enterprises in China, and a Shanghai Stock Exchange A-share listed company with stock code 600566. The company oversees Jumpcan Pharmaceutical Group Co., Ltd. and Shanghai Jijia Investment Co., Ltd. Jumpcan Pharmaceutical Group Co., Ltd. governs subsidiaries such as Tianji Pharmaceutical, Jiuyuan Medicine, Pudilan Daily Chemicals, E-commerce Company, Kangxuyuan Health Products, Jiren TCM Decoction Pieces, Ginkgo Industry Research Institute, and Oral Health Research Institute. Shanghai Jijia Investment Co., Ltd. oversees subsidiaries like Ningbo Jijia Investment and Dongke Pharmaceutical.Jumpcan promotes the corporate spirit of "solidarity and inclusiveness" along with the core values of "innovation, diligence, and win-win," adhering to the "four ones" value creation philosophy. It practices the "five-with" talent concept—"talent as the foundation, talent as capital, attracting talent with benefits, nurturing talent through careers, and retaining talent with emotion"—and advocates for "two requirements," leading corporate development with its unique culture.Jumpcan upholds the corporate mission of "using technology to safeguard health" and advocates the R&D concept of "leading the frontier, innovating premium products." It implements strategies of "focusing on five fields to promote growth and innovating academic marketing concepts," specializing in the production and sales of medicines in pediatrics, oral care, respiratory, digestive, gynecology, obstetrics, and other areas. The company has a product portfolio with over 10 dosage forms and more than 210 specifications of nationally approved drugs. Over 110 product specifications, including Pediatric Chaiqiao Qingre Granules (Tongbei), Jianwei Xiaoshi Oral Liquid, and San'ao Tablets, are included in the National Medical Insurance Catalog, with 68 specifications entering the National Essential Medicines List. In 2020, three new products—Chuanxiong Qingnao Granules, Ganhai Weikang Capsules, and Levetiracetam Injection Concentrate Solution—were added to the National Medical Insurance Catalog. More than 10 products, such as Pudilan and Chuanxiong, are exclusive domestic varieties, exclusive formulations, Jiangsu Province high-tech products, and Jiangsu Province famous brands. The "Shou" brand trademark is a well-known trademark in China, while the "Tongxiao" trademark is a renowned trademark in Jiangsu Province. Pediatric Chaiqiao Qingre Granules (Tongbei) have been awarded the "most recognized pediatric brand by grassroots doctors," selected as a clinically valuable traditional Chinese medicine brand in 2020, and became the most highly recommended brand by Chinese pharmacy staff. Pudilan Anti-inflammatory Oral Liquid won the "most popular star product in pharmacies" and "recommended family medication," topping the 2020 "Healthy China Brand List · Throat and Oral Care Category" and being included in the *Science and Technology Competitiveness Report of Large TCM Varieties (2019)*. The next-generation proton pump inhibitor Rabeprazole Sodium Enteric-coated Capsules (Jinuo) were selected for the "2020 China Medicine · Brand List." Jianwei Xiaoshi Oral Liquid was honored as a "medicine-food homology recommended product." Leading the TCM daily chemical products are Pudilan Keyanning Toothpaste, Pudilan Keyanning Antiseptic Mouthwash, and Pudilan Keyanning Antiseptic Oral Spray, which continue to strengthen market competitiveness and advance the rapid development of the broader health industry.